BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1366 related articles for article (PubMed ID: 22508111)

  • 1. Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study.
    Treede H; Mohr FW; Baldus S; Rastan A; Ensminger S; Arnold M; Kempfert J; Figulla HR
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e131-8. PubMed ID: 22508111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transapical transcatheter aortic valve implantation using a new second-generation TAVI system - J-Valve™ for high-risk patients with aortic valve diseases: Initial results with 90-day follow-up.
    Zhu D; Chen Y; Guo Y; Hu J; Zhang J; Wei X; Tang H; Shi Y
    Int J Cardiol; 2015 Nov; 199():155-62. PubMed ID: 26197402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValve™.
    Kempfert J; Rastan AJ; Mohr FW; Walther T
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):761-3. PubMed ID: 21334914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-apical aortic valve implantation using a new self-expandable bioprosthesis: initial outcomes.
    Kempfert J; Rastan AJ; Beyersdorf F; Schönburg M; Schuler G; Sorg S; Mohr FW; Walther T
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1114-9. PubMed ID: 21924620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up.
    Schlingloff F; Schäfer U; Frerker C; Schmoeckel M; Bader R
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):388-93. PubMed ID: 24893871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation.
    Seiffert M; Bader R; Kappert U; Rastan A; Krapf S; Bleiziffer S; Hofmann S; Arnold M; Kallenbach K; Conradi L; Schlingloff F; Wilbring M; Schäfer U; Diemert P; Treede H
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1168-74. PubMed ID: 25129672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcarotid aortic valve-in-valve implantation for degenerated stentless aortic root conduits with severe regurgitation: a case series.
    Huber C; Praz F; O'Sullivan CJ; Langhammer B; Gloekler S; Stortecky S; von Allmen RS; Meier B; Carrel T; Englberger L; Windecker S; Wenaweser P
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):694-700. PubMed ID: 25776924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transapical transcatheter aortic valve implantation without prior balloon aortic valvuloplasty: feasible and safe.
    Conradi L; Seiffert M; Schirmer J; Koschyk D; Blankenberg S; Reichenspurner H; Diemert P; Treede H
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):61-6. PubMed ID: 24335266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transapical aortic valve implantation in patients with previous cardiac surgery.
    Papadopoulos N; Ilioska P; Fichtlscherer S; Lehmann R; Beiras Fernandez A; Moritz A; Doss M; Zierer A
    Ann Thorac Surg; 2014 Jan; 97(1):37-42. PubMed ID: 24075497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement].
    Zahn R; Schiele R; Kilkowski C; Klein B; Schwarz AK; Zeymer U; Lehmann A; Cornelius B; Horack M; Saggau W; Werling C
    Dtsch Med Wochenschr; 2010 Aug; 135(33):1589-95. PubMed ID: 20717862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus.
    Wendler O; Thielmann M; Schroefel H; Rastan A; Treede H; Wahlers T; Eichinger W; Walther T
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):371-7. PubMed ID: 22522982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JenaValve.
    Treede H; Rastan A; Ferrari M; Ensminger S; Figulla HR; Mohr FW
    EuroIntervention; 2012 Sep; 8 Suppl Q():Q88-93. PubMed ID: 22995119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected complications of transapical aortic valve implantation.
    Al-Attar N; Ghodbane W; Himbert D; Rau C; Raffoul R; Messika-Zeitoun D; Brochet E; Vahanian A; Nataf P
    Ann Thorac Surg; 2009 Jul; 88(1):90-4. PubMed ID: 19559200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate follow-up results from the multicenter engager European pivotal trial.
    Holzhey D; Linke A; Treede H; Baldus S; Bleiziffer S; Wagner A; Börgermann J; Scholtz W; Vanoverschelde JL; Falk V
    Ann Thorac Surg; 2013 Dec; 96(6):2095-100. PubMed ID: 24021766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PREVAIL TRANSAPICAL: multicentre trial of transcatheter aortic valve implantation using the newly designed bioprosthesis (SAPIEN-XT) and delivery system (ASCENDRA-II).
    Walther T; Thielmann M; Kempfert J; Schroefel H; Wimmer-Greinecker G; Treede H; Wahlers T; Wendler O
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):278-83; discussion 283. PubMed ID: 22293620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics.
    Saia F; Lemos PA; Bordoni B; Cervi E; Boriani G; Ciuca C; Taglieri N; Mariani J; Kalil Filho R; Marzocchi A
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):712-9. PubMed ID: 22109957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves.
    Eggebrecht H; Schäfer U; Treede H; Boekstegers P; Babin-Ebell J; Ferrari M; Möllmann H; Baumgartner H; Carrel T; Kahlert P; Lange P; Walther T; Erbel R; Mehta RH; Thielmann M
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1218-27. PubMed ID: 22115663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA™): 6-month outcomes.
    Kempfert J; Treede H; Rastan AJ; Schönburg M; Thielmann M; Sorg S; Mohr FW; Walther T
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):52-6; discussion 57. PubMed ID: 22491663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transapical aortic valve implantation in Rouen: four years' experience with the Edwards transcatheter prosthesis.
    Litzler PY; Borz B; Smail H; Baste JM; Nafeh-Bizet C; Gay A; Tron C; Godin M; Caudron J; Hauville C; Dacher JN; Cribier A; Eltchaninoff H; Bessou JP
    Arch Cardiovasc Dis; 2012 Mar; 105(3):141-5. PubMed ID: 22520796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.